Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Polycystic Ovary Syndrome × Folic Acid × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Ovary Syndrome 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Meningeal Carcinomatosis 1 Hyperbilirubinemia 1

Interventions

Metformin 18 Inositol 12 Letrozole 7 Tablets 3 Exercise 3 Estradiol 3 semaglutide 2 maltodextrin 2 drospirenone and ethinyl estradiol combination 2 artenimol 2 Spironolactone 2 Progesterone 2 Magnesium 2 Liraglutide 2 Ethinyl Estradiol 2 Docosahexaenoic Acids 2 Diet Therapy 2 Contraceptives, Oral, Combined 2 Clomiphene 2 Caloric Restriction 2 salicylsalicylic acid 1 mirabegron 1 ganirelix 1 etonogestrel 1 empagliflozin 1 drospirenone 1 cetrorelix 1 Walking 1 Transcranial Direct Current Stimulation 1 Thyroxine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04881851 2025-04-16

IALA

Universita di Verona

Phase NA Terminated

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡